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ABSTRACT 
The neuropeptides S1 (GFNSALMFamide) and S2 (SGPYSFNSGLTFamide), which 
share sequence similarity, were discovered in the starfish Asterias rubens and are prototypical 
members of the SALMFamide family of neuropeptides in echinoderms. SALMFamide 
neuropeptides act as muscle relaxants and both S1 and S2 cause relaxation of cardiac stomach 
and tube foot preparations in vitro but S2 is an order of magnitude more potent than S1. Here we 
investigated a structural basis for this difference in potency using spectroscopic techniques. 
Circular dichroism spectroscopy showed that S1 does not have a defined structure in aqueous 
solution and this was supported by 2D nuclear magnetic resonance experiments. In contrast, we 
found that S2 has a well-defined conformation in aqueous solution. However, the conformation 
of S2 was concentration dependent, with increasing concentration inducing a transition from an 
unstructured to a structured conformation. Interestingly, this property of S2 was not observed in 
an N-terminally truncated analog of S2 (short S2 or SS2; SFNSGLTFamide). Collectively, the 
data obtained indicate that the N-terminal region of S2 facilitates peptide self-association at high 
concentrations, which may have relevance to the biosynthesis and/or bioactivity of S2 in vivo. 
 
Keywords: neuropeptide, SALMFamide, circular dichroism, NMR, muscle relaxant, self-
association
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1.0 Introduction 
 
 The SALMFamides are a family of neuropeptides that act as muscle relaxants in species 
belonging to the phylum Echinodermata (e.g. starfish, sea urchins, sea cucumbers). Two types of 
SALMFamides have been identified in echinoderms: L-type SALMFamides, which have the C-
terminal motif SxLxFamide, and F-type SALMFamides, which have the C-terminal motif 
SxFxFamide [1, 2]. The first members of the SALMFamide neuropeptide family to be identified 
were two L-type SALMFamides, S1 and S2, which were both isolated from the nervous system 
of the starfish species Asterias rubens and Asterias forbesi [3]. S1 is an amidated octapeptide 
(Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2) and S2 is an amidated dodecapeptide (Ser-Gly-Pro-
Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2), which share the C-terminal sequence Phe-Asn-
Ser-X-Leu-X-Phe-NH2 (where X is variable). 
Investigation of the physiological roles of S1 and S2 has revealed that injection of these 
peptides into starfish (Asterias rubens) causes eversion of the cardiac stomach. Consistent with 
these in vivo effects, analysis of the effects of S1 and S2 in vitro revealed that both peptides 
cause relaxation of the cardiac stomach [4]. These findings are of interest from a physiological 
and behavioural perspective because starfish feed by everting their cardiac stomach over the 
digestible parts of prey such as mussels and oysters.  Therefore, S1 and/or S2 may mediate 
neural control of stomach eversion in starfish in vivo by causing relaxation of muscle associated 
with the cardiac stomach. Consistent with this notion, immunocytochemical studies have 
revealed that S1 and S2 are present in nerve fibres in close proximity to the muscle layer of the 
cardiac stomach [5]. Furthermore, S1 and S2 appear to be expressed in different populations of 
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neurons in Asterias rubens [5, 6] and consistent with this observation recent analysis of the 
genome sequence of the starfish Patiria miniata has revealed that S1 and an S2-like peptide are 
encoded by different genes [7].  
Comparison of the effectiveness of S1 and S2 as muscle relaxants in starfish has revealed 
that S2 is more effective than S1 when tested at the same concentration (10 µM) on three 
different preparations from Asterias rubens: the cardiac stomach, tube feet and the body wall 
apical muscle [8]. Furthermore, extrapolated dose-response data indicate that S2 may be 
approximately ten times more potent than S1 [1]. However, a direct comparison of the potency 
of S1 and S2 as muscle relaxants in starfish has as yet not been conducted. Therefore, here we 
have compared the relaxing effects of both S1 and S2 at a range of concentrations on two 
different preparations, the cardiac stomach and tube feet. 
It is not known if S1 and S2 exert their relaxing effects on starfish muscle preparations by 
binding to a single receptor type or via different receptors, although it is assumed that these 
peptides act on G protein-coupled receptors [1]. Nevertheless, given the similarity of the C-
terminal regions of S1 (FNSALMFamide) and S2 (FNSGLTFamide), we hypothesized that the 
presence of four additional N-terminal residues in S2 (SGPY) may influence its structure in 
solution and account, at least in part, for differences in the potency of S1 and S2. To address this 
issue, here we have used circular dichroism (CD) and nuclear magnetic resonance (NMR) 
spectroscopy to analyse and compare the conformations of S1 and S2 in aqueous solution.  
Previous studies on other neuropeptides comparable in size to S1 and S2 have revealed 
that they exist in aqueous solution as an ensemble of rapidly interconverting structures lacking 
stable secondary or tertiary structural elements [9]. For example, the neuropeptide neurotensin, 
which comprises thirteen amino acid residues, exists mainly as a flexible “random coil” 
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polypeptide chain in water [10, 11].  Similarly, the mammalian tachykinin peptides substance P, 
neurokinin A and neurokinin B and the non-mammalian tachykinins physalaemin, eledoisin and 
kassinin all adopt a variety of interconverting conformational states in water [12-16]. Therefore, 
our expectation was that both S1 and S2 would similarly adopt multiple conformational states in 
aqueous solution. Surprisingly, however, we have discovered that S2, but not S1, has a 
remarkably well-defined conformation in aqueous solution, and the structuring is caused by self-
association. The structural basis and functional relevance of this property of S2 is investigated 
and discussed. 
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2.0 Materials and Methods 
 
2.1 Materials - Peptides were custom-synthesized by the Advanced Biotechnology Centre at 
Imperial College London and purified using high performance liquid chromatography. All other 
chemicals used were obtained from VWR (Poole, Dorset, UK) with the exception of D2O, which 
was obtained from Goss Scientific Instruments Ltd (Great Baddow, Essex, UK). 
 
2.2 In vitro pharmacology - Starfish (Asterias rubens) were obtained from the Menai Straits 
(UK) and then maintained in a circulating seawater aquarium in the School of Biological & 
Chemical Sciences at QMUL. Cardiac stomach preparations were dissected from animals 
ranging in diameter from 12 – 16 cm and then linked to an isotonic transducer (model 60-3001; 
Harvard, South Natick, MA, USA) in a 20 ml organ bath containing aerated seawater at 11°C, as 
described previously [1, 17]. Changes in cardiac stomach length were recorded on a chart 
recorder (Goerz Servogor 124). Sustained contracture of the cardiac stomach was induced and 
maintained using seawater with 30 mM added KCl, as described previously [4]. Solutions of S1 
and S2 were then prepared in water and added (20 µl) to the organ bath to achieve final bath 
concentrations of 0.001, 0.01, 0.1 and 1 µM. S1 and S2 were tested on a total of fifteen cardiac 
stomach preparations, with both peptides being applied twice at each concentration tested. The 
order in which different peptides and concentrations were tested was random after having first 
tested 1 µM S2. Preparations were washed between tests by refilling the organ bath several times 
with seawater/KCl and then allowing a 15-20 min interval before the next test, during which time 
preparations regained basal resting length. The effects of each peptide concentration tested were 
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normalised to the effect of 1 µM S2 and mean % relaxation values were calculated for both S1 
and S2 at each of the concentrations tested. 
 The relaxing effects of S1 and S2 on tube foot preparations were also compared at a 
range of concentrations, recording under isotonic conditions as described previously [8]. At 
concentrations below 0.1 µM, the magnitudes of the relaxing effects observed were too small to 
be consistently measurable and therefore comparison of the effects of S1 and S2 was limited to 
tests at 0.1, 1 and 10 µM. 
 An N-terminally truncated analog of S2 (short S2 or SS2; SFNSGLTFamide) was also 
tested on both cardiac stomach and tube foot preparations to enable comparison of its bioactivity 
with that of S1 and S2. 
 
2.3 Circular Dichroism (CD) spectroscopy - CD spectra were recorded using a Chirascan CD 
spectrometer (Applied Photophysics Ltd.) equipped with a Peltier temperature controller. Spectra 
were the average of three scans recorded with a 1 nm bandwidth, a 0.5 nm step size, and a 5 s 
time constant. After background subtraction, the observed ellipticity (T; mdeg) was converted to 
a molar ellipticity ('(; M-1 cm-1), using the formula: '( = T/(33000 lc) where l is the path length 
(cm) and c is the concentration (M). To investigate the effect of pH on CD spectra, the pH of the 
peptide solution was altered using 10 mM NaOH or 10 mM HCl to achieve four pH values in the 
range 5.3 – 8.4. Samples were then incubated for 20 min prior to recording CD spectra. To 
examine the effect of temperature, CD spectra were obtained at 10, 20, 30, 40 and 50qC. Thermal 
unfolding of S2 was also investigated up to 90qC using a 1 mm path length for a 0.1 mg/ml 
sample and a 1 cm path length for a 0.01 mg/ml sample. 
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2.4 NMR spectroscopy - Peptides were dissolved in 10% D2O/90% H2O to achieve a final 
concentration of 2 mM. The pH of the solutions was adjusted to pH 5.6 using 10 mM NaOH and 
10 mM HCl. The peptide solutions were centrifuged to remove any suspended material and then 
the supernatant was transferred to 5 mm NMR tubes. Data were acquired using a Bruker Avance 
600 MHz spectrometer and collected using Topspin software on a UNIX workstation. All 
experiments were performed using a 5 mm TXI, triple resonance probe equipped with a z-axis 
gradient. 2D NMR spectra were obtained at 293 K for S1, 303 K for S2 and 283 K for SS2. 
Water suppression was achieved using a Water Gradient Tailored Excitation (WATERGATE) 
technique. 2D-Total Correlation Spectroscopy (TOCSY) experiments employed a DIPSI2 
sequence for isotropic mixing, with a 75 ms mixing time unless otherwise noted. A 300 ms 
mixing time was used for Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotational 
Overhauser Effect Spectroscopy (ROESY) experiments.  All 2D experiments used STATES-
TPPI phase cycling, and a spectral width of 14 ppm was applied in both dimensions with 2048 x 
512 complex data points in the t2 and t1 dimensions, respectively. Prior to Fourier 
Transformation (FT), the data were linear predicted in the F1 dimension to 512 real points and 
then zero filled to produce a final matrix size of 4k x 1k, with 90o phase-shifted sine squared 
window function applied to both dimensions. The chemical shifts were referenced to water at 4.7 
ppm at 303K, pH 5.6, based on the method of Cavanagh et al. [18]. Spin-systems were manually 
assigned using the TOCSY data and sequential assignments were completed using the 300 ms 
NOESY spectrum [19]. Chemical shift data for S2 have been deposited in the Biological 
Magnetic Resonance Data Bank (code 18940). 
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3.0 Results 
 
3.1 S2 is an order of magnitude more potent than S1- Previous studies using extrapolated dose-
response data indicated that S2 is a more potent muscle relaxant than S1 [1]. Here we directly 
compared the relaxing effects of S1 and S2 at a range of concentrations on starfish cardiac 
stomach and tube foot preparations. S1 and S2 were tested on cardiac stomach preparations at 1 
nM, 0.01 PM, 0.1 PM and 1 PM and the relaxing effect of S2 was found to be larger than the 
effect of S1 at all concentrations tested (Fig. 1A).  Furthermore, the effect of 1 PM S1 (68 ± 8 %) 
was not significantly different (p = 0.71; t-test) to the effect of one-tenth the concentration of S2 
(0.1 PM) (66 ± 7 %). Similarly, the effect of 0.1 PM S1 (34 ± 6%) was not significantly different 
(p = 0.89; t-test) to the effect of 0.01 PM S2 (33 ± 8%). S1 and S2 were also tested on tube foot 
preparations at 0.1 PM, 1.0 PM and 10 PM and, as with cardiac stomach preparations, the 
relaxing effect of S2 was found to be larger than the effect of S1 at all concentrations tested (Fig. 
1B). Moreover, the magnitude of the difference in the relaxing activity of S1 and S2 was greater 
with tube foot preparations than with cardiac stomach preparations. For example, at 1 PM the 
mean relaxing effect of S1 was 68% of the mean effect of S2 on cardiac stomach preparations, 
whereas on tube feet the mean relaxing effect of S1 was only 14% of the effect of S2. These data 
demonstrate that S2 is at least an order of magnitude more potent than S1 as a muscle relaxant in 
starfish. This difference in the potency/activity of S1 and S2 as muscle relaxants in starfish 
provided a rationale for comparative analysis of the solution conformations of these peptides 
using CD spectroscopy and NMR spectroscopy. 
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3.2 CD spectroscopy of S1 and S2- CD spectroscopy in the far UV range was used to investigate 
the secondary structure propensity of S1 and S2 in aqueous solution and the effect of temperature 
and pH on their main-chain conformations (Fig. 2). The CD spectra obtained for S1 (Fig. 2A, B) 
have a strong negative band at 200 nm along with a weak positive band at 218 nm. These CD 
bands suggest that S1 has predominantly an irregular random-coil conformation in aqueous 
solution [20]. Varying the temperature from 10qC to 50qC (at pH 5.5; Fig. 2A) and the pH from 
5.3 to 8.3 (at 11oC; Fig. 2B) had little effect on the appearance of the CD spectra.  Both resulted 
in a slight reduction in the amplitude of the bands at 200 nm and 218 nm but no shift in the 
wavelength of each of the peaks.  The lack of a shift in the wavelengths suggests that S1 remains 
unstructured over this range of pHs and temperatures.  
The CD spectra for S2 were quite different to those obtained for S1, with negative bands 
at 207 nm and 196 nm and a weak positive band at 228 nm (Fig. 2C, 10qC spectrum). These 
spectra are different to those observed with peptides that have D-helical or E-sheet type 
conformations; however, they are also inconsistent with a random coil conformation, which are 
characterized by a single negative CD band at ~198 nm. It is possible that S2 adopts an extended 
conformation that does not contain formal E-strands; this is also supported by NMR chemical 
shift analysis and the absence of main-chain hydrogen bonding (discussed in section 3.5). The 
negative peak near 198 nm is suggestive of an unstructured peptide, but proline residues are 
known to have transitions at 198 nm, with the trans Xxx-Pro bond having a negative Cotton 
effect and the cis Xxx-Pro bond having a positive effect at 198 nm [21, 22]. It is likely that the 
CD band at 198 nm for S2 is a combination of signals from a structured, proline-containing 
peptide along with „random coil‟ type signals. The slight intensity reduction at 207 nm and 228 
nm as the temperature increases (Fig. 2C) could be due to some loss of overall structure. 
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Increasing the pH from 5.5 to 8.4 reduced the negative band at 196 nm, broadened negative 
bands at 207 nm and resulted in loss of the positive band at 228 nm (Fig. 2D). Change in pH can 
affect the Xxx-pro cis-trans equilibrium and it is plausible that the loss of the negative signal at 
198 nm is a result of a greater proportion of the cis isoform at high pHs. Above neutrality the 
peak at 207 nm not only broadens but also moves to longer wavelengths with a concomitant 
decrease in the intensity of the 228 nm positive peak. Possibly, the increasing pH causes the 
structure to adopt some E-turns. Indeed, E-turns tend to have a positive signal near 200 nm and a 
slight negative signal near 220. The appearance of E-turn-like structure might also account for 
the loss of negative intensity around 198 nm.  Overall, and over a range of pH values, it is clear 
that temperatures up to 30oC do not cause S2 to unfold into an irregular structure. Based on these 
observations we chose to study both S1 and S2 further using NMR at pH 5.8 and 30 qC. 
 
3.3 1H NMR comparison of S1 and S2- Two-dimensional NMR spectra were obtained for both 
S1 and S2 in order to determine if any unique structures existed. From the 2D TOCSY spectra 
we were able to assign complete spin systems for all but Gly1 and Phe2 of S1 (supplementary 
material Table S1A). The 1D spectrum (Fig. 3) shows considerable line broadening of Phe2 
suggesting that the N-terminus of S1 is exchange broadened, undergoing milli-to-micro second 
time-scale motions. Furthermore, the limited chemical shift dispersion of the amide protons 
suggests the S1 peptide is unstructured. The NOESY spectrum for S1 gave a few weak NOE 
cross-peaks for intra-residue NOEs suggesting that the size of the peptide and the resulting 
correlation time causes the NOE to be weak and close to the null. For this reason, a ROESY 
spectrum was obtained from which we were able to obtain sequential assignments as shown in 
Fig. 3 (HD-HN fingerprint region). It was possible to unambiguously assign all peaks present as 
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S1 contained six unique amino acids and two phenylalanines. However, only sequential 
connectivities were observed for S1 and no long range ROEs that would be indicative of stable 
structure were apparent. The fact that the ROESY spectrum of S1 provided no further 
information beyond a limited number of sequential assignments is entirely consistent with the 
CD data, which indicated that S1 exists in a random-coil conformation. 
From the TOCSY spectrum of S2 (Fig. 4A) we were able to assign all but Ser1 and, in 
contrast to S1, we were able to obtain a 1H-1H NOESY spectrum that contains a remarkable 
number of cross peaks (the complete 300 ms NOESY spectrum is shown as supplementary 
material Fig. S1).  Sequential assignments for S2 were readily achieved using standard 2D 
methods [19] and are shown as supplementary material Table S1B. The HD-HN fingerprint region 
is shown in Fig. 4B, and from this a complete sequential path could be followed from Ser1 
through to the C-terminal amide on Phe12, with only a break at Pro3. In the spectrum there were 
two sets of peaks associated with the N-terminal residues Gly2, Pro3, Tyr4 and Ser5, and one set 
was more intense than the other (Fig. 4B). In the aliphatic region (see supplementary material 
Fig. S1), a strong dDG(i, i+1) NOE was observed between the Gly2 and Pro3 for the most intense 
set of peaks indicating that these originated from a trans conformation around the Gly2-Pro3 
peptide bond. The lower intensity peaks had a dDD(i, i+1) between Gly2 and Pro3 consistent with 
a cis conformation. The large chemical shift differences between residues in the cis and trans 
conformations, notably Tyr4 and Ser5 observed in Fig. 4B, is likely due to the different 
conformation of the aromatic side-chain of Tyr4, and the consequently altered ring-current 
effects. On intensity measurements, the trans-conformation is about 80-85% prevalent. A weak 
dNN(i, i+1) NOE is apparent between Ser5Cis and Phe6 (data not shown), which suggests that 
residues beyond Ser5 are not influenced by the cis-trans isomerism and they have the same 
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structure in each isoform. This is also supported by the presence of an NOE between the Ser5Cis 
E-protons and the ring protons of Phe6 (data not shown).     
The HD-HN region shows several NOEs indicative of substantial order in S2. For instance, 
dDN(i, i+2) connections are readily observed for residues from Gly2 through to Thr11 and a longer 
range dDN(i, i+3) NOE and a weak dDN(i, i+4) are observed from Gly2 to Ser5 and Phe6 
respectively. Further, dEN(i, i+1,2,3) NOEs are apparent for the E-protons of Ser5 and Ser8. Along 
with the dDN connections, there are also several, relatively weak, dNN(i, i+2) connections for Tyr4, 
Ser5, Phe6 and Ser8 (data not shown). Remarkably, in all there were more than 220 NOEs 
observed for the S2 peptide.  We were surprised by this amount of structuring, as indicated by 
the large number of NOEs, for such a small (12 residue) peptide and were intrigued as to the 
source of the structuring in the absence of disulphide bonds. 
In the absence of disulphide bonds, it is possible that extensive backbone hydrogen 
bonding hold S2 in a rigid conformation. To investigate this we explored the temperature 
dependence of amide proton NMR resonances. 1H NMR amide temperature coefficients can be a 
reliable indicator of the presence of hydrogen bonding.  In particular, temperature coefficients of 
between -1 ppb/K and -4 ppb/K indicate a high probability (93%) of the presence of a hydrogen-
bonded amide [23, 24]. 1D spectra for S2 were obtained over a range of temperatures and the 
change in amide proton chemical shift as a function of temperature (283 K – 313 K) was 
determined. Table 1 shows that for S2 the smallest temperature coefficient observed is |-4.6| 
ppb/K for Leu10, a value which can predict a hydrogen bond in more than 85% of cases. The 
temperature coefficients for the other amides in S2 suggest hydrogen bonding is unlikely to 
occur. Experiments with S1 did not show any temperature coefficient small enough to predict 
any hydrogen bonding. Furthermore, 3JHDNH coupling constants for S2 are not indicative of any 
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regular secondary structure. So with no extensive hydrogen bonding network, why is there so 
much structuring of S2, as apparent from the large number of NOE contacts observed and also 
evident in the CD spectra? 
 
3.4 Structuring of S2 is caused by self-association- Next we investigated the concentration 
dependence of the CD spectrum for the S2 peptide.  It is clear from Fig. 5A that the structuring 
of the S2 peptide is highly concentration dependant. An increase in concentration from 0.01 
mg/ml to 0.1 and 0.2 mg/ml (the concentration at which the NMR data was obtained) causes a 
profound increase in the structuring of the S2 peptide, as indicated by a strong negative CD band 
at 216 nm, typical of an extended-conformation.  With the strong concentration dependence of 
the CD spectra it is clear that self-association is the source of the observed structuring of S2. At 
the lower concentration (0.01 mg/ml) there is little structuring of S2 with a single weak negative 
CD band at 198 nm, typical of irregular structure. 
We went on and studied the thermal stability of the S2 peptide, at two different 
concentrations. At 0.1 mg/ml S2 undergoes a clear thermal unfolding transition. The unfolding 
curve has a sigmoidal appearance typical for cooperative, essentially two-state unfolding, with a 
mid-point at 55qC (Fig. 5B). The temperature dependence of the CD spectra for S2 at 0.01 
mg/ml is very different; there is no cooperative unfolding with temperature. The increase in 
temperature causes a loss of some PP-II character in the spectra, but a co-operative unfolding 
transition is not apparent for the dilute S2 sample. 
 Given that the CD data suggests that S2 self-associates at the concentrations used here for 
NMR, NOESY peaks other than the intense sequential NOEs may arise from intra- or inter-
peptide contacts. For instance, the E-protons of Ser5 have clear NOEs to the amide protons of 
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Phe6, Asn7 and Ser8 along with a reasonably intense NOE to the amide proton of Tyr4 (Fig. 4B). 
Although the gradually weakening NOEs to residues 6, 7, and 8 could be expected to be intra-
peptide, the NOE to Tyr4 may arise from an intra-peptide contact or from an inter-peptide 
contact.  Although there are a large number of NOEs (220 pairs), and particularly because of the 
small size of the peptide, determining which of these NOEs are intra-molecular and which are 
inter-molecular is difficult.  Thus, standard approaches to generate a monomeric solution 
structure from the NOE data set are not appropriate.  Nevertheless, the large number of NOEs 
and the ability to observe a well resolved set of resonances for residues Gly2 to Phe12 indicates 
that self-association induces a single, soluble, low molecular mass structure in S2. The narrow 
line-widths of the amide NMR peaks (~4 Hz, at half-height) suggest that the size of the complex 
is small, perhaps only dimeric. Obtaining NMR spectra at lower concentrations in order to 
differentiate inter-molecular NOEs from intra-molecular ones is problematic as disrupting the 
oligomer also causes loss of structure.  Therefore, we cannot assume that loss of a particular 
NOE necessarily indicates it is a inter-molecular contact as loss of structure means only 
sequential NOEs are observed, as seen for S1 (Fig. 3). 
 
3.5 Evidence of a role for the N-terminal region of S2 in self-association- The clear difference 
between S1 and S2 in their solution conformations is intriguing given their sequence similarity. 
However, S2 has the N-terminal sequence SGPY that is absent in S1. To determine if this 
sequence impacted on the self-association property of S2, we constructed a modified S2 peptide 
that lacks this N-terminal sequence (short S2 or SS2; SFNSGLTFamide). The TOCSY and 
ROESY spectra of this peptide, at the same concentration as S2, are shown overlaid in Fig. 6A. 
The dispersion of amide peaks in the 1D spectrum is similar to that of S1 and suggests a lack of 
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regular structure. Moreover, the array of NOEs apparent in S2 (Fig. 4B) is missing in SS2 and 
only sequential NOEs are visible (Fig 6A). The lack of a large number of NOEs in the spectrum 
of SS2 suggests that the N-terminal sequence SGPY is an important factor in the self-association 
of S2 and subsequent generation of a defined structure. Aromatic amino acids can often associate 
via S-S interactions and it is plausible that Tyr4 is required to support such interactions and 
therefore S2 self-association. Intriguingly, analysis of the HDchemical shift index (i.e. deviation 
from „random coil‟) of S2 and SS2 shows that they are reasonably similar (Fig. 6B), but 
dissimilar to S1 (Fig. 6C). Note that although trending negative from Phe6, the CSI shifts for S2 
and SS2 are not great enough to suggest any true E-sheet-like structure exists. Nevertheless, the 
similarity between S2 and SS2 shifts suggests that SS2 may be accessing the same 
conformational space as is S2 despite not forming a defined structure. 
    
3.6 Analysis of the bioactivity of SS2- Having analysed the solution conformation of SS2 in 
comparison with S2, it was of interest to compare the bioactivity of SS2 with that of S1 and S2. 
Therefore, we tested SS2 on the two preparations that we originally used (Fig. 1) to compare the 
pharmacological activity of S1 and S2 – starfish cardiac stomach and tube foot preparations. 
 Consistent with relaxing effects of S1 and S2, SS2 caused dose-dependent relaxation of 
cardiac stomach preparations when tested at 0.1 PM, 1 PM and 10 PM (Fig. 7A). Comparison of 
the relaxing actions of S1, SS2 and S2 when tested at 1 PM revealed that SS2 was significantly 
more effective than S1 (p = 0.0004; t-test) and slightly, but significantly (p = 0.03; t-test), less 
effective than S2 (Fig. 7B). These findings indicate that the biological activity of S2 is largely 
attributable to its C-terminal octapeptide sequence (SFNSGLTFamide). 
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Next an analysis of the effects of SS2 on tube foot preparations yielded some interesting 
findings. As with the cardiac stomach preparations, SS2 caused dose dependent relaxation of 
tube-feet (Fig. 7C). However, it was noteworthy that the effects of SS2 at 10 PM were 
consistently larger than the effects of S2 at the same concentration. When the effects of S1, S2 
and SS2 were compared at 1 PM, SS2 was significantly (p = 0.00006; t-test) more effective than 
S1 and significantly (p = 0.000003; t-test) less effective than S2 (Fig. 7D). Thus, for tube foot 
preparations conflicting conclusions can be drawn from the data obtained, with results from tests 
at 10 PM indicating that the presence of the N-terminal SGPY sequence actually impairs the 
bioactivity of S2, while results from tests at 1 PM indicate that the presence of the N-terminal 
SGPY sequence contributes to the bioactivity of S2.  
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4.0 Discussion 
S2 is related to the SALMFamide neuropeptide S1 (GFNSALMFamide), which shares 
with S2 the C-terminal sequence motif FNSxLxFamide (where is x is variable). Both S1 and S2 
cause muscle relaxation in starfish but S2 is more effective than S1 when tested at the same 
concentration [8]. Here we have specifically compared the potency of S1 and S2 by testing both 
peptides at a range of concentrations on two different preparations from the starfish Asterias 
rubens, the cardiac stomach and tube feet. These experiments revealed that S2 is at least an order 
of magnitude more potent than S1, which provided the rationale for a comparative investigation 
of the solution structures of S1 and S2 using CD and NMR spectroscopy. 
CD spectroscopy indicates that S1 is largely unstructured in aqueous solution and, 
consistent with the CD data, the NMR NOESY spectrum of S1 showed only sequential NOEs, 
which implies a lack of a unique, stable conformation. This is in line with other neuropeptide 
studies showing that small peptides like S1 are usually unstructured in aqueous solutions [9-16]. 
In contrast, the NMR NOESY spectrum for S2 showed a remarkable array of NOE cross-peaks 
(220 NOE pairs) indicative of a well-structured peptide. The HD chemical shift analysis, the lack 
of regular hydrogen bonding and the pattern of NOEs, all indicate that S2 is not composed of a 
regular D-helical or E-sheet like structure. However, the sequence of S2 has polar, hydrophilic 
amino acids interspersed with hydrophobic and aromatic amino acids, which may support the 
generation of some structure. Keire et al. [9] have shown that an eight residue cholecystokinin 
peptide CCK8 (DYMGWMDF-NH2) in aqueous solution has a preference for J-and E-turns 
around GWMD and MDF-NH2. In the case of S2, the structure adopted is dependent on the 
peptide concentration. At lower concentrations S2 is unstructured, and presumably monomeric, 
whereas increasing the concentration induces structure, which is likely due to the formation of 
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low molecular weight oligomers, perhaps dimers. However, because of the small size of the 
peptide it is not possible to ascertain, from the numerous NOEs observed, the type of contacts 
between S2 peptides  (i.e. head-to-head or head-to-tail).  
Many neuropeptides that are unstructured and flexible in aqueous solvents tend to adopt 
structure when in the presence of stabilising solvents such as alcohols (trifluoroethanol, for 
instance), as well as in the presence of membranes. This finding has led to the proposition of a 
two-step theory of neuropeptide/receptor interaction wherein the neuropeptide binds first to the 
membrane and then undergoes diffusion to the appropriate receptor [25]. It is envisaged that 
interaction with the membrane not only reduces the degrees of freedom but also stabilises 
conformations that promote receptor binding. 
Our discovery that S2 has a well defined, but concentration dependent conformation in 
aqueous solution may have physiological implications. The concentration of neuropeptides in 
vesicles prior to release is high and structuring may support a higher degree of packing in 
vesicles. Furthermore, high peptide concentrations may persist locally after release and therefore 
analysis of the self-association structure and process may be relevant to function. Indeed, studies 
with neuropeptide Y, whose physiological roles include regulation of food intake and pain 
perception, have shown that the hydrophobic residues that support self-association in this peptide 
also allow binding to cell membranes [26]. 
The conformation of S2 in aqueous solution may explain why S2 is more potent than S1 
as a muscle relaxant in starfish. We speculate that S2 might bind to its receptor as an oligomer 
(dimer) and that the solution conformation of S2 is the same or very similar to its conformation 
when bound to a receptor. Therefore the probability of receptor-binding and receptor-activation 
may be greater than for a peptide (S1) that lacks a well-defined conformation in aqueous solution 
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and that will have an entropic penalty when binding to its receptor. Earlier studies on 
FMRFamide-like peptides have shown that, although not adopting a unique conformation, some 
can contain significant populations of turns and the percentage of turns is highly correlated with 
IC50 values of receptor binding [27]. This suggests that the presence of structure in neuropeptides 
confers an added level of „fine-tuning‟ of receptor interactions.  
  Clearly the key structural difference between S1 and S2 is the presence of four N-
terminal residues (SGPY) in S2 that are lacking in S1. It appears, therefore, that the presence of 
these residues confers on S2 an ability to adopt a stable conformation in solution upon self-
association. Our finding that S2 and SS2 (short S2) have similar HD chemical shift indexes 
suggests that SS2 may explore a conformation similar to that adopted by S2 at the same 
concentration, but a stable structure is not generated. Accordingly, differences in the C-terminal 
regions of S1 and S2 clearly contribute to the differing potencies of S1 and S2 because tests with 
SS2 revealed that it is significantly more active as a muscle relaxant than S1. It is the N-terminal 
SGPY motif in S2 that appears to be the key to its conformational stability in aqueous solution 
and this motif contributes to superior bioactivity of S2 compared to both SS2 and S1 when tested 
at 1 µM and 10 µM on cardiac stomach preparations and when tested at 1 µM on tube 
preparations. However, our finding that SS2 is more active as a muscle relaxant than S2 when 
tested on tube feet at 10 µM suggests complex structure-activity relationships, which may be 
influenced by the combinations of receptor types that are expressed in different organs. Further 
investigation of this issue will be possible if the receptors that mediate the effects of 
SALMFamides are identified (see [28] for a discussion of a potential strategy for identification 
of SALMFamide receptors). If there are multiple receptor types that mediate the effects of 
SALMFamides, then tissue-specific differential expression of receptor types may explain why 
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dose-dependent differences in the relative activity S1, S2 and a synthetic analog of S2 (SS2) are 
observed. 
From a physiological perspective it is of interest to consider why two peptides (S1 and 
S2) with the same effect (muscle relaxation) but with different potencies both exist in starfish. 
Immunocytochemical studies have revealed that S1 and S2 are expressed by different 
populations of neurons in the starfish Asterias rubens and this finding is supported by analysis of 
the genome sequence of the starfish Patiria miniata, which has revealed that S1 and an S2-like 
peptide are derived from precursor proteins encoded by different genes [7]. Moreover, in 
Asterias rubens S2 is detected by radioimmunoassay in the perivisceral coelomic fluid whereas 
S1 is not [17]. This suggests that S2 may act as a hormonal signalling molecule in starfish and 
therefore it would be necessary for its potency to be greater than that of S1, which may only act 
more locally as a neurotransmitter or paracrine signalling molecule. Thus, we speculate that the 
structural features of S2 that confer on it greater potency compared to S1 may be molecular 
adaptations for a hormonal signalling role. 
Finally, it has recently been discovered that in the starfish Patiria miniata, S1 is derived 
from a precursor protein that comprises six other putative L-type or L-type-like SALMFamides 
[7]. On the other hand, the S2-like neuropeptide in this species is derived from a different 
precursor protein that comprises eight F-type or F-type-like SALMFamides [7]. Our 
investigation of a structural basis for differences in the activity of S1 and S2, as reported here, 
therefore provides the foundations for further studies on more complex “cocktails” of 
SALMFamides that occur in vivo.   
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FIGURE LEGENDS 
Fig. 1. Comparison of the potency of S1 and S2 as muscle relaxants. A, Graph comparing the 
relaxing effects of S1 (filled bar) and S2 (empty bar) (0.001 – 1 µM) on starfish cardiac stomach 
preparations, expressed as a mean percentage (± SEM; n = 15) of the effect of 1 µM S2. The 
effect of 1 µM S1 is not significantly different (p = 0.71; t-test) to the effect of 0.1 PM S2 and 
the effect of 0.1 PM S1 is not significantly different (p = 0.89; t-test) to the effect of 0.01 PM S2. 
B, Graph comparing the relaxing effects of S1 and S2 (0.1 – 10 µM) on starfish tube foot 
preparations, expressed as a mean percentage (± SEM; n = 4 for S1; n = 18 for S2) of the effect 
of 10 µM S2.  
 
Fig. 2. CD spectra of S1 and S2 peptides in water. A, CD of S1 as the temperature changes at 
constant pH (5.3). Varying the temperature from 10qC to 50qC had little effect on the CD 
spectra, with just a slight reduction in the amplitude of the CD signal. B, CD of S1 as the pH 
changes from pH 5.3 to pH 8.3 at constant temperature (11qC). Similarly, there is a slight 
reduction in the amplitude of the CD signal as the pH increases. In both A and B there is a strong 
negative band at 200 nm characteristic of a random coil conformation. C. CD of S2  at different 
temperatures and constant pH (5.5). Increasing the temperature from 10qC to 50qC results in a 
slight reduction in the amplitude of the negative bands at 196 nm and 207 nm. D, Increasing the 
pH (at a constant temperature of 11qC) from 5.5 to 8.4 reduces the negative band at 196 nm and 
causes the negative band at 207 nm to shift to longer wavelengths.  
 
Fig. 3. ROESY spectrum of S1. The HD-HN fingerprint region of the S1 neuropeptide ROESY 
(Wm 300 ms) spectrum at 293K, pH 5.6, showing the dDN(i, i+1) assignments of S1. The box 
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around F2 denotes the HD-HN peak that is observed in the TOCSY spectrum but not in the 
ROESY spectrum. 
 
Fig. 4. NMR data for S2 highlights the presence of structure. A, The HD-HN finger print region of 
the S2 TOCSY (Wm 75 ms) spectrum in water at 303K, pH 5.6 showing spin-system assignment. 
B, The HD-HN fingerprint region of the S2 NOESY (Wm 300 ms) spectrum in water at 303K, pH 
5.6. Solid lines show the dDN(i, i+1) sequential assignments of S2. Dashed lines identify residues 
from the cis-Pro3 isoform. 
 
Fig. 5: Concentration dependence of S2 peptide structure and folding stability. Far UV-CD 
spectra of S2, showing concentration dependent secondary structure of S2 at 0.01 mg/ml (7.8 
µM) (red), 0.1 mg/ml (78 µM) (black) and 0.2 mg/ml (156 µM) (blue) (A). Thermal denaturation 
of S2, between 10-90oC, blue spectra are from 10oC and red are at 80oC.  Spectra were obtained 
at two concentrations; 0.1 mg/ml (B), and 0.01 mg/ml of S2 (C). Inserts are thermal denaturation 
curves at 210 nm and 228 nm, respectively.  
 
Fig. 6. NMR analysis of SS2 (short S2). A, the HD-HN fingerprint region of the TOCSY (blue, Wm 
65 ms) and ROESY (red, (Wm 300 ms) spectra of SS2 shown overlaid. The sequential dDN(i, i+1) 
assignments are shown with solid lines.  B, HD chemical shift analysis of S2 (black bars) and SS2 
(white bars). C, HD chemical shift analysis of S1. 
 
Fig. 7. Analysis of the effects of SS2 as a muscle relaxant and comparison of the activity of SS2 
with S1 and S2. A, SS2 causes dose-dependent relaxation of starfish cardiac stomach 
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preparations; error bars represent mean ± SEM (n=5) and data are normalised to the effect of S2 
at 10 PM. B, Comparison of the relaxing effect of SS2 to that of S2 and S1 on cardiac stomach 
(all at 1 PM). Data are normalised to relaxation effect of S2 (at 1 PM); error bars represent mean 
± SEM (n=12). Significance *** = p < 0.001 (students t-test). C, SS2 causes dose-dependent 
relaxation of starfish tube foot preparations; error bars represent mean ± SEM (n=9) and data are 
normalised to the effect of S2 at 10 PM. D, Comparison of the relaxing effect of SS2 to that of 
S2 and S1 on tube feet. Data are normalised to relaxation effect of S2 (1 PM); error bars 
represent mean ± SEM (n=13). Significance *** = p < 0.001, *  =  p<0.05. 
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ABSTRACT 
The neuropeptides S1 (GFNSALMFamide) and S2 (SGPYSFNSGLTFamide), which 
share sequence similarity, were discovered in the starfish Asterias rubens and are prototypical 
members of the SALMFamide family of neuropeptides in echinoderms. SALMFamide 
neuropeptides act as muscle relaxants and both S1 and S2 cause relaxation of cardiac stomach 
and tube foot preparations in vitro but S2 is an order of magnitude more potent than S1. Here we 
investigated a structural basis for this difference in potency using spectroscopic techniques. 
Circular dichroism spectroscopy showed that S1 does not have a defined structure in aqueous 
solution and this was supported by 2D nuclear magnetic resonance experiments. In contrast, we 
found that S2 has a well-defined conformation in aqueous solution. However, the conformation 
of S2 was concentration dependent, with increasing concentration inducing a transition from an 
unstructured to a structured conformation. Interestingly, this property of S2 was not observed in 
an N-terminally truncated analog of S2 (short S2 or SS2; SFNSGLTFamide). Collectively, the 
data obtained indicate that the N-terminal region of S2 facilitates peptide self-association at high 
concentrations, which may have relevance to the biosynthesis and/or bioactivity of S2 in vivo. 
 
Keywords: neuropeptide, SALMFamide, circular dichroism, NMR, muscle relaxant, self-
association
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1.0 Introduction 
 
 The SALMFamides are a family of neuropeptides that act as muscle relaxants in species 
belonging to the phylum Echinodermata (e.g. starfish, sea urchins, sea cucumbers). Two types of 
SALMFamides have been identified in echinoderms: L-type SALMFamides, which have the C-
terminal motif SxLxFamide, and F-type SALMFamides, which have the C-terminal motif 
SxFxFamide [1, 2]. The first members of the SALMFamide neuropeptide family to be identified 
were two L-type SALMFamides, S1 and S2, which were both isolated from the nervous system 
of the starfish species Asterias rubens and Asterias forbesi [3]. S1 is an amidated octapeptide 
(Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2) and S2 is an amidated dodecapeptide (Ser-Gly-Pro-
Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2), which share the C-terminal sequence Phe-Asn-
Ser-X-Leu-X-Phe-NH2 (where X is variable). 
Investigation of the physiological roles of S1 and S2 has revealed that injection of these 
peptides into starfish (Asterias rubens) causes eversion of the cardiac stomach. Consistent with 
these in vivo effects, analysis of the effects of S1 and S2 in vitro revealed that both peptides 
cause relaxation of the cardiac stomach [4]. These findings are of interest from a physiological 
and behavioural perspective because starfish feed by everting their cardiac stomach over the 
digestible parts of prey such as mussels and oysters.  Therefore, S1 and/or S2 may mediate 
neural control of stomach eversion in starfish in vivo by causing relaxation of muscle associated 
with the cardiac stomach. Consistent with this notion, immunocytochemical studies have 
revealed that S1 and S2 are present in nerve fibres in close proximity to the muscle layer of the 
cardiac stomach [5]. Furthermore, S1 and S2 appear to be expressed in different populations of 
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neurons in Asterias rubens [5, 6] and consistent with this observation recent analysis of the 
genome sequence of the starfish Patiria miniata has revealed that S1 and an S2-like peptide are 
encoded by different genes [7].  
Comparison of the effectiveness of S1 and S2 as muscle relaxants in starfish has revealed 
that S2 is more effective than S1 when tested at the same concentration (10 µM) on three 
different preparations from Asterias rubens: the cardiac stomach, tube feet and the body wall 
apical muscle [8]. Furthermore, extrapolated dose-response data indicate that S2 may be 
approximately ten times more potent than S1 [1]. However, a direct comparison of the potency 
of S1 and S2 as muscle relaxants in starfish has as yet not been conducted. Therefore, here we 
have compared the relaxing effects of both S1 and S2 at a range of concentrations on two 
different preparations, the cardiac stomach and tube feet. 
It is not known if S1 and S2 exert their relaxing effects on starfish muscle preparations by 
binding to a single receptor type or via different receptors, although it is assumed that these 
peptides act on G protein-coupled receptors [1]. Nevertheless, given the similarity of the C-
terminal regions of S1 (FNSALMFamide) and S2 (FNSGLTFamide), we hypothesized that the 
presence of four additional N-terminal residues in S2 (SGPY) may influence its structure in 
solution and account, at least in part, for differences in the potency of S1 and S2. To address this 
issue, here we have used circular dichroism (CD) and nuclear magnetic resonance (NMR) 
spectroscopy to analyse and compare the conformations of S1 and S2 in aqueous solution.  
Previous studies on other neuropeptides comparable in size to S1 and S2 have revealed 
that they exist in aqueous solution as an ensemble of rapidly interconverting structures lacking 
stable secondary or tertiary structural elements [9]. For example, the neuropeptide neurotensin, 
which comprises thirteen amino acid residues, exists mainly as a flexible “random coil” 
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polypeptide chain in water [10, 11].  Similarly, the mammalian tachykinin peptides substance P, 
neurokinin A and neurokinin B and the non-mammalian tachykinins physalaemin, eledoisin and 
kassinin all adopt a variety of interconverting conformational states in water [12-16]. Therefore, 
our expectation was that both S1 and S2 would similarly adopt multiple conformational states in 
aqueous solution. Surprisingly, however, we have discovered that S2, but not S1, has a 
remarkably well-defined conformation in aqueous solution, and the structuring is caused by self-
association. The structural basis and functional relevance of this property of S2 is investigated 
and discussed. 
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2.0 Materials and Methods 
 
2.1 Materials - Peptides were custom-synthesized by the Advanced Biotechnology Centre at 
Imperial College London and purified using high performance liquid chromatography. All other 
chemicals used were obtained from VWR (Poole, Dorset, UK) with the exception of D2O, which 
was obtained from Goss Scientific Instruments Ltd (Great Baddow, Essex, UK). 
 
2.2 In vitro pharmacology - Starfish (Asterias rubens) were obtained from the Menai Straits 
(UK) and then maintained in a circulating seawater aquarium in the School of Biological & 
Chemical Sciences at QMUL. Cardiac stomach preparations were dissected from animals 
ranging in diameter from 12 – 16 cm and then linked to an isotonic transducer (model 60-3001; 
Harvard, South Natick, MA, USA) in a 20 ml organ bath containing aerated seawater at 11°C, as 
described previously [1, 17]. Changes in cardiac stomach length were recorded on a chart 
recorder (Goerz Servogor 124). Sustained contracture of the cardiac stomach was induced and 
maintained using seawater with 30 mM added KCl, as described previously [4]. Solutions of S1 
and S2 were then prepared in water and added (20 µl) to the organ bath to achieve final bath 
concentrations of 0.001, 0.01, 0.1 and 1 µM. S1 and S2 were tested on a total of fifteen cardiac 
stomach preparations, with both peptides being applied twice at each concentration tested. The 
order in which different peptides and concentrations were tested was random after having first 
tested 1 µM S2. Preparations were washed between tests by refilling the organ bath several times 
with seawater/KCl and then allowing a 15-20 min interval before the next test, during which time 
preparations regained basal resting length. The effects of each peptide concentration tested were 
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normalised to the effect of 1 µM S2 and mean % relaxation values were calculated for both S1 
and S2 at each of the concentrations tested. 
 The relaxing effects of S1 and S2 on tube foot preparations were also compared at a 
range of concentrations, recording under isotonic conditions as described previously [8]. At 
concentrations below 0.1 µM, the magnitudes of the relaxing effects observed were too small to 
be consistently measurable and therefore comparison of the effects of S1 and S2 was limited to 
tests at 0.1, 1 and 10 µM. 
 An N-terminally truncated analog of S2 (short S2 or SS2; SFNSGLTFamide) was also 
tested on both cardiac stomach and tube foot preparations to enable comparison of its bioactivity 
with that of S1 and S2. 
 
2.3 Circular Dichroism (CD) spectroscopy - CD spectra were recorded using a Chirascan CD 
spectrometer (Applied Photophysics Ltd.) equipped with a Peltier temperature controller. Spectra 
were the average of three scans recorded with a 1 nm bandwidth, a 0.5 nm step size, and a 5 s 
time constant. After background subtraction, the observed ellipticity (T; mdeg) was converted to 
a molar ellipticity ('(; M-1 cm-1), using the formula: '( = T/(33000 lc) where l is the path length 
(cm) and c is the concentration (M). To investigate the effect of pH on CD spectra, the pH of the 
peptide solution was altered using 10 mM NaOH or 10 mM HCl to achieve four pH values in the 
range 5.3 – 8.4. Samples were then incubated for 20 min prior to recording CD spectra. To 
examine the effect of temperature, CD spectra were obtained at 10, 20, 30, 40 and 50qC. Thermal 
unfolding of S2 was also investigated up to 90qC using a 1 mm path length for a 0.1 mg/ml 
sample and a 1 cm path length for a 0.01 mg/ml sample. 
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2.4 NMR spectroscopy - Peptides were dissolved in 10% D2O/90% H2O to achieve a final 
concentration of 2 mM. The pH of the solutions was adjusted to pH 5.6 using 10 mM NaOH and 
10 mM HCl. The peptide solutions were centrifuged to remove any suspended material and then 
the supernatant was transferred to 5 mm NMR tubes. Data were acquired using a Bruker Avance 
600 MHz spectrometer and collected using Topspin software on a UNIX workstation. All 
experiments were performed using a 5 mm TXI, triple resonance probe equipped with a z-axis 
gradient. 2D NMR spectra were obtained at 293 K for S1, 303 K for S2 and 283 K for SS2. 
Water suppression was achieved using a Water Gradient Tailored Excitation (WATERGATE) 
technique. 2D-Total Correlation Spectroscopy (TOCSY) experiments employed a DIPSI2 
sequence for isotropic mixing, with a 75 ms mixing time unless otherwise noted. A 300 ms 
mixing time was used for Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotational 
Overhauser Effect Spectroscopy (ROESY) experiments.  All 2D experiments used STATES-
TPPI phase cycling, and a spectral width of 14 ppm was applied in both dimensions with 2048 x 
512 complex data points in the t2 and t1 dimensions, respectively. Prior to Fourier 
Transformation (FT), the data were linear predicted in the F1 dimension to 512 real points and 
then zero filled to produce a final matrix size of 4k x 1k, with 90o phase-shifted sine squared 
window function applied to both dimensions. The chemical shifts were referenced to water at 4.7 
ppm at 303K, pH 5.6, based on the method of Cavanagh et al. [18]. Spin-systems were manually 
assigned using the TOCSY data and sequential assignments were completed using the 300 ms 
NOESY spectrum [19]. Chemical shift data for S2 have been deposited in the Biological 
Magnetic Resonance Data Bank (code 18940). 
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3.0 Results 
 
3.1 S2 is an order of magnitude more potent than S1- Previous studies using extrapolated dose-
response data indicated that S2 is a more potent muscle relaxant than S1 [1]. Here we directly 
compared the relaxing effects of S1 and S2 at a range of concentrations on starfish cardiac 
stomach and tube foot preparations. S1 and S2 were tested on cardiac stomach preparations at 1 
nM, 0.01 PM, 0.1 PM and 1 PM and the relaxing effect of S2 was found to be larger than the 
effect of S1 at all concentrations tested (Fig. 1A).  Furthermore, the effect of 1 PM S1 (68 ± 8 %) 
was not significantly different (p = 0.71; t-test) to the effect of one-tenth the concentration of S2 
(0.1 PM) (66 ± 7 %). Similarly, the effect of 0.1 PM S1 (34 ± 6%) was not significantly different 
(p = 0.89; t-test) to the effect of 0.01 PM S2 (33 ± 8%). S1 and S2 were also tested on tube foot 
preparations at 0.1 PM, 1.0 PM and 10 PM and, as with cardiac stomach preparations, the 
relaxing effect of S2 was found to be larger than the effect of S1 at all concentrations tested (Fig. 
1B). Moreover, the magnitude of the difference in the relaxing activity of S1 and S2 was greater 
with tube foot preparations than with cardiac stomach preparations. For example, at 1 PM the 
mean relaxing effect of S1 was 68% of the mean effect of S2 on cardiac stomach preparations, 
whereas on tube feet the mean relaxing effect of S1 was only 14% of the effect of S2. These data 
demonstrate that S2 is at least an order of magnitude more potent than S1 as a muscle relaxant in 
starfish. This difference in the potency/activity of S1 and S2 as muscle relaxants in starfish 
provided a rationale for comparative analysis of the solution conformations of these peptides 
using CD spectroscopy and NMR spectroscopy. 
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3.2 CD spectroscopy of S1 and S2- CD spectroscopy in the far UV range was used to investigate 
the secondary structure propensity of S1 and S2 in aqueous solution and the effect of temperature 
and pH on their main-chain conformations (Fig. 2). The CD spectra obtained for S1 (Fig. 2A, B) 
have a strong negative band at 200 nm along with a weak positive band at 218 nm. These CD 
bands suggest that S1 has predominantly an irregular random-coil conformation in aqueous 
solution [20]. Varying the temperature from 10qC to 50qC (at pH 5.5; Fig. 2A) and the pH from 
5.3 to 8.3 (at 11oC; Fig. 2B) had little effect on the appearance of the CD spectra.  Both resulted 
in a slight reduction in the amplitude of the bands at 200 nm and 218 nm but no shift in the 
wavelength of each of the peaks.  The lack of a shift in the wavelengths suggests that S1 remains 
unstructured over this range of pHs and temperatures.  
The CD spectra for S2 were quite different to those obtained for S1, with negative bands 
at 207 nm and 196 nm and a weak positive band at 228 nm (Fig. 2C, 10qC spectrum). These 
spectra are different to those observed with peptides that have D-helical or E-sheet type 
conformations; however, they are also inconsistent with a random coil conformation, which are 
characterized by a single negative CD band at ~198 nm. It is possible that S2 adopts an extended 
conformation that does not contain formal E-strands; this is also supported by NMR chemical 
shift analysis and the absence of main-chain hydrogen bonding (discussed in section 3.5). The 
negative peak near 198 nm is suggestive of an unstructured peptide, but proline residues are 
known to have transitions at 198 nm, with the trans Xxx-Pro bond having a negative Cotton 
effect and the cis Xxx-Pro bond having a positive effect at 198 nm [21, 22]. It is likely that the 
CD band at 198 nm for S2 is a combination of signals from a structured, proline-containing 
peptide along with „random coil‟ type signals. The slight intensity reduction at 207 nm and 228 
nm as the temperature increases (Fig. 2C) could be due to some loss of overall structure. 
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Increasing the pH from 5.5 to 8.4 reduced the negative band at 196 nm, broadened negative 
bands at 207 nm and resulted in loss of the positive band at 228 nm (Fig. 2D). Change in pH can 
affect the Xxx-pro cis-trans equilibrium and it is plausible that the loss of the negative signal at 
198 nm is a result of a greater proportion of the cis isoform at high pHs. Above neutrality the 
peak at 207 nm not only broadens but also moves to longer wavelengths with a concomitant 
decrease in the intensity of the 228 nm positive peak. Possibly, the increasing pH causes the 
structure to adopt some E-turns. Indeed, E-turns tend to have a positive signal near 200 nm and a 
slight negative signal near 220. The appearance of E-turn-like structure might also account for 
the loss of negative intensity around 198 nm.  Overall, and over a range of pH values, it is clear 
that temperatures up to 30oC do not cause S2 to unfold into an irregular structure. Based on these 
observations we chose to study both S1 and S2 further using NMR at pH 5.8 and 30 qC. 
 
3.3 1H NMR comparison of S1 and S2- Two-dimensional NMR spectra were obtained for both 
S1 and S2 in order to determine if any unique structures existed. From the 2D TOCSY spectra 
we were able to assign complete spin systems for all but Gly1 and Phe2 of S1 (supplementary 
material Table S1A). The 1D spectrum (Fig. 3) shows considerable line broadening of Phe2 
suggesting that the N-terminus of S1 is exchange broadened, undergoing milli-to-micro second 
time-scale motions. Furthermore, the limited chemical shift dispersion of the amide protons 
suggests the S1 peptide is unstructured. The NOESY spectrum for S1 gave a few weak NOE 
cross-peaks for intra-residue NOEs suggesting that the size of the peptide and the resulting 
correlation time causes the NOE to be weak and close to the null. For this reason, a ROESY 
spectrum was obtained from which we were able to obtain sequential assignments as shown in 
Fig. 3 (HD-HN fingerprint region). It was possible to unambiguously assign all peaks present as 
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S1 contained six unique amino acids and two phenylalanines. However, only sequential 
connectivities were observed for S1 and no long range ROEs that would be indicative of stable 
structure were apparent. The fact that the ROESY spectrum of S1 provided no further 
information beyond a limited number of sequential assignments is entirely consistent with the 
CD data, which indicated that S1 exists in a random-coil conformation. 
From the TOCSY spectrum of S2 (Fig. 4A) we were able to assign all but Ser1 and, in 
contrast to S1, we were able to obtain a 1H-1H NOESY spectrum that contains a remarkable 
number of cross peaks (the complete 300 ms NOESY spectrum is shown as supplementary 
material Fig. S1).  Sequential assignments for S2 were readily achieved using standard 2D 
methods [19] and are shown as supplementary material Table S1B. The HD-HN fingerprint region 
is shown in Fig. 4B, and from this a complete sequential path could be followed from Ser1 
through to the C-terminal amide on Phe12, with only a break at Pro3. In the spectrum there were 
two sets of peaks associated with the N-terminal residues Gly2, Pro3, Tyr4 and Ser5, and one set 
was more intense than the other (Fig. 4B). In the aliphatic region (see supplementary material 
Fig. S1), a strong dDG(i, i+1) NOE was observed between the Gly2 and Pro3 for the most intense 
set of peaks indicating that these originated from a trans conformation around the Gly2-Pro3 
peptide bond. The lower intensity peaks had a dDD(i, i+1) between Gly2 and Pro3 consistent with 
a cis conformation. The large chemical shift differences between residues in the cis and trans 
conformations, notably Tyr4 and Ser5 observed in Fig. 4B, is likely due to the different 
conformation of the aromatic side-chain of Tyr4, and the consequently altered ring-current 
effects. On intensity measurements, the trans-conformation is about 80-85% prevalent. A weak 
dNN(i, i+1) NOE is apparent between Ser5Cis and Phe6 (data not shown), which suggests that 
residues beyond Ser5 are not influenced by the cis-trans isomerism and they have the same 
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structure in each isoform. This is also supported by the presence of an NOE between the Ser5Cis 
E-protons and the ring protons of Phe6 (data not shown).     
The HD-HN region shows several NOEs indicative of substantial order in S2. For instance, 
dDN(i, i+2) connections are readily observed for residues from Gly2 through to Thr11 and a longer 
range dDN(i, i+3) NOE and a weak dDN(i, i+4) are observed from Gly2 to Ser5 and Phe6 
respectively. Further, dEN(i, i+1,2,3) NOEs are apparent for the E-protons of Ser5 and Ser8. Along 
with the dDN connections, there are also several, relatively weak, dNN(i, i+2) connections for Tyr4, 
Ser5, Phe6 and Ser8 (data not shown). Remarkably, in all there were more than 220 NOEs 
observed for the S2 peptide.  We were surprised by this amount of structuring, as indicated by 
the large number of NOEs, for such a small (12 residue) peptide and were intrigued as to the 
source of the structuring in the absence of disulphide bonds. 
In the absence of disulphide bonds, it is possible that extensive backbone hydrogen 
bonding hold S2 in a rigid conformation. To investigate this we explored the temperature 
dependence of amide proton NMR resonances. 1H NMR amide temperature coefficients can be a 
reliable indicator of the presence of hydrogen bonding.  In particular, temperature coefficients of 
between -1 ppb/K and -4 ppb/K indicate a high probability (93%) of the presence of a hydrogen-
bonded amide [23, 24]. 1D spectra for S2 were obtained over a range of temperatures and the 
change in amide proton chemical shift as a function of temperature (283 K – 313 K) was 
determined. Table 1 shows that for S2 the smallest temperature coefficient observed is |-4.6| 
ppb/K for Leu10, a value which can predict a hydrogen bond in more than 85% of cases. The 
temperature coefficients for the other amides in S2 suggest hydrogen bonding is unlikely to 
occur. Experiments with S1 did not show any temperature coefficient small enough to predict 
any hydrogen bonding. Furthermore, 3JHDNH coupling constants for S2 are not indicative of any 
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regular secondary structure. So with no extensive hydrogen bonding network, why is there so 
much structuring of S2, as apparent from the large number of NOE contacts observed and also 
evident in the CD spectra? 
 
3.4 Structuring of S2 is caused by self-association- Next we investigated the concentration 
dependence of the CD spectrum for the S2 peptide.  It is clear from Fig. 5A that the structuring 
of the S2 peptide is highly concentration dependant. An increase in concentration from 0.01 
mg/ml to 0.1 and 0.2 mg/ml (the concentration at which the NMR data was obtained) causes a 
profound increase in the structuring of the S2 peptide, as indicated by a strong negative CD band 
at 216 nm, typical of an extended-conformation.  With the strong concentration dependence of 
the CD spectra it is clear that self-association is the source of the observed structuring of S2. At 
the lower concentration (0.01 mg/ml) there is little structuring of S2 with a single weak negative 
CD band at 198 nm, typical of irregular structure. 
We went on and studied the thermal stability of the S2 peptide, at two different 
concentrations. At 0.1 mg/ml S2 undergoes a clear thermal unfolding transition. The unfolding 
curve has a sigmoidal appearance typical for cooperative, essentially two-state unfolding, with a 
mid-point at 55qC (Fig. 5B). The temperature dependence of the CD spectra for S2 at 0.01 
mg/ml is very different; there is no cooperative unfolding with temperature. The increase in 
temperature causes a loss of some PP-II character in the spectra, but a co-operative unfolding 
transition is not apparent for the dilute S2 sample. 
 Given that the CD data suggests that S2 self-associates at the concentrations used here for 
NMR, NOESY peaks other than the intense sequential NOEs may arise from intra- or inter-
peptide contacts. For instance, the E-protons of Ser5 have clear NOEs to the amide protons of 
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Phe6, Asn7 and Ser8 along with a reasonably intense NOE to the amide proton of Tyr4 (Fig. 4B). 
Although the gradually weakening NOEs to residues 6, 7, and 8 could be expected to be intra-
peptide, the NOE to Tyr4 may arise from an intra-peptide contact or from an inter-peptide 
contact.  Although there are a large number of NOEs (220 pairs), and particularly because of the 
small size of the peptide, determining which of these NOEs are intra-molecular and which are 
inter-molecular is difficult.  Thus, standard approaches to generate a monomeric solution 
structure from the NOE data set are not appropriate.  Nevertheless, the large number of NOEs 
and the ability to observe a well resolved set of resonances for residues Gly2 to Phe12 indicates 
that self-association induces a single, soluble, low molecular mass structure in S2. The narrow 
line-widths of the amide NMR peaks (~4 Hz, at half-height) suggest that the size of the complex 
is small, perhaps only dimeric. Obtaining NMR spectra at lower concentrations in order to 
differentiate inter-molecular NOEs from intra-molecular ones is problematic as disrupting the 
oligomer also causes loss of structure.  Therefore, we cannot assume that loss of a particular 
NOE necessarily indicates it is a inter-molecular contact as loss of structure means only 
sequential NOEs are observed, as seen for S1 (Fig. 3). 
 
3.5 Evidence of a role for the N-terminal region of S2 in self-association- The clear difference 
between S1 and S2 in their solution conformations is intriguing given their sequence similarity. 
However, S2 has the N-terminal sequence SGPY that is absent in S1. To determine if this 
sequence impacted on the self-association property of S2, we constructed a modified S2 peptide 
that lacks this N-terminal sequence (short S2 or SS2; SFNSGLTFamide). The TOCSY and 
ROESY spectra of this peptide, at the same concentration as S2, are shown overlaid in Fig. 6A. 
The dispersion of amide peaks in the 1D spectrum is similar to that of S1 and suggests a lack of 
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regular structure. Moreover, the array of NOEs apparent in S2 (Fig. 4B) is missing in SS2 and 
only sequential NOEs are visible (Fig 6A). The lack of a large number of NOEs in the spectrum 
of SS2 suggests that the N-terminal sequence SGPY is an important factor in the self-association 
of S2 and subsequent generation of a defined structure. Aromatic amino acids can often associate 
via S-S interactions and it is plausible that Tyr4 is required to support such interactions and 
therefore S2 self-association. Intriguingly, analysis of the HDchemical shift index (i.e. deviation 
from „random coil‟) of S2 and SS2 shows that they are reasonably similar (Fig. 6B), but 
dissimilar to S1 (Fig. 6C). Note that although trending negative from Phe6, the CSI shifts for S2 
and SS2 are not great enough to suggest any true E-sheet-like structure exists. Nevertheless, the 
similarity between S2 and SS2 shifts suggests that SS2 may be accessing the same 
conformational space as is S2 despite not forming a defined structure. 
    
3.6 Analysis of the bioactivity of SS2- Having analysed the solution conformation of SS2 in 
comparison with S2, it was of interest to compare the bioactivity of SS2 with that of S1 and S2. 
Therefore, we tested SS2 on the two preparations that we originally used (Fig. 1) to compare the 
pharmacological activity of S1 and S2 – starfish cardiac stomach and tube foot preparations. 
 Consistent with relaxing effects of S1 and S2, SS2 caused dose-dependent relaxation of 
cardiac stomach preparations when tested at 0.1 PM, 1 PM and 10 PM (Fig. 7A). Comparison of 
the relaxing actions of S1, SS2 and S2 when tested at 1 PM revealed that SS2 was significantly 
more effective than S1 (p = 0.0004; t-test) and slightly, but significantly (p = 0.03; t-test), less 
effective than S2 (Fig. 7B). These findings indicate that the biological activity of S2 is largely 
attributable to its C-terminal octapeptide sequence (SFNSGLTFamide). 
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Next an analysis of the effects of SS2 on tube foot preparations yielded some interesting 
findings. As with the cardiac stomach preparations, SS2 caused dose dependent relaxation of 
tube-feet (Fig. 7C). However, it was noteworthy that the effects of SS2 at 10 PM were 
consistently larger than the effects of S2 at the same concentration. When the effects of S1, S2 
and SS2 were compared at 1 PM, SS2 was significantly (p = 0.00006; t-test) more effective than 
S1 and significantly (p = 0.000003; t-test) less effective than S2 (Fig. 7D). Thus, for tube foot 
preparations conflicting conclusions can be drawn from the data obtained, with results from tests 
at 10 PM indicating that the presence of the N-terminal SGPY sequence actually impairs the 
bioactivity of S2, while results from tests at 1 PM indicate that the presence of the N-terminal 
SGPY sequence contributes to the bioactivity of S2.  
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4.0 Discussion 
S2 is related to the SALMFamide neuropeptide S1 (GFNSALMFamide), which shares 
with S2 the C-terminal sequence motif FNSxLxFamide (where is x is variable). Both S1 and S2 
cause muscle relaxation in starfish but S2 is more effective than S1 when tested at the same 
concentration [8]. Here we have specifically compared the potency of S1 and S2 by testing both 
peptides at a range of concentrations on two different preparations from the starfish Asterias 
rubens, the cardiac stomach and tube feet. These experiments revealed that S2 is at least an order 
of magnitude more potent than S1, which provided the rationale for a comparative investigation 
of the solution structures of S1 and S2 using CD and NMR spectroscopy. 
CD spectroscopy indicates that S1 is largely unstructured in aqueous solution and, 
consistent with the CD data, the NMR NOESY spectrum of S1 showed only sequential NOEs, 
which implies a lack of a unique, stable conformation. This is in line with other neuropeptide 
studies showing that small peptides like S1 are usually unstructured in aqueous solutions [9-16]. 
In contrast, the NMR NOESY spectrum for S2 showed a remarkable array of NOE cross-peaks 
(220 NOE pairs) indicative of a well-structured peptide. The HD chemical shift analysis, the lack 
of regular hydrogen bonding and the pattern of NOEs, all indicate that S2 is not composed of a 
regular D-helical or E-sheet like structure. However, the sequence of S2 has polar, hydrophilic 
amino acids interspersed with hydrophobic and aromatic amino acids, which may support the 
generation of some structure. Keire et al. [9] have shown that an eight residue cholecystokinin 
peptide CCK8 (DYMGWMDF-NH2) in aqueous solution has a preference for J-and E-turns 
around GWMD and MDF-NH2. In the case of S2, the structure adopted is dependent on the 
peptide concentration. At lower concentrations S2 is unstructured, and presumably monomeric, 
whereas increasing the concentration induces structure, which is likely due to the formation of 
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low molecular weight oligomers, perhaps dimers. However, because of the small size of the 
peptide it is not possible to ascertain, from the numerous NOEs observed, the type of contacts 
between S2 peptides  (i.e. head-to-head or head-to-tail).  
Many neuropeptides that are unstructured and flexible in aqueous solvents tend to adopt 
structure when in the presence of stabilising solvents such as alcohols (trifluoroethanol, for 
instance), as well as in the presence of membranes. This finding has led to the proposition of a 
two-step theory of neuropeptide/receptor interaction wherein the neuropeptide binds first to the 
membrane and then undergoes diffusion to the appropriate receptor [25]. It is envisaged that 
interaction with the membrane not only reduces the degrees of freedom but also stabilises 
conformations that promote receptor binding. 
Our discovery that S2 has a well defined, but concentration dependent conformation in 
aqueous solution may have physiological implications. The concentration of neuropeptides in 
vesicles prior to release is high and structuring may support a higher degree of packing in 
vesicles. Furthermore, high peptide concentrations may persist locally after release and therefore 
analysis of the self-association structure and process may be relevant to function. Indeed, studies 
with neuropeptide Y, whose physiological roles include regulation of food intake and pain 
perception, have shown that the hydrophobic residues that support self-association in this peptide 
also allow binding to cell membranes [26]. 
The conformation of S2 in aqueous solution may explain why S2 is more potent than S1 
as a muscle relaxant in starfish. We speculate that S2 might bind to its receptor as an oligomer 
(dimer) and that the solution conformation of S2 is the same or very similar to its conformation 
when bound to a receptor. Therefore the probability of receptor-binding and receptor-activation 
may be greater than for a peptide (S1) that lacks a well-defined conformation in aqueous solution 
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and that will have an entropic penalty when binding to its receptor. Earlier studies on 
FMRFamide-like peptides have shown that, although not adopting a unique conformation, some 
can contain significant populations of turns and the percentage of turns is highly correlated with 
IC50 values of receptor binding [27]. This suggests that the presence of structure in neuropeptides 
confers an added level of „fine-tuning‟ of receptor interactions.  
  Clearly the key structural difference between S1 and S2 is the presence of four N-
terminal residues (SGPY) in S2 that are lacking in S1. It appears, therefore, that the presence of 
these residues confers on S2 an ability to adopt a stable conformation in solution upon self-
association. Our finding that S2 and SS2 (short S2) have similar HD chemical shift indexes 
suggests that SS2 may explore a conformation similar to that adopted by S2 at the same 
concentration, but a stable structure is not generated. Accordingly, differences in the C-terminal 
regions of S1 and S2 clearly contribute to the differing potencies of S1 and S2 because tests with 
SS2 revealed that it is significantly more active as a muscle relaxant than S1. It is the N-terminal 
SGPY motif in S2 that appears to be the key to its conformational stability in aqueous solution 
and this motif contributes to superior bioactivity of S2 compared to both SS2 and S1 when tested 
at 1 µM and 10 µM on cardiac stomach preparations and when tested at 1 µM on tube 
preparations. However, our finding that SS2 is more active as a muscle relaxant than S2 when 
tested on tube feet at 10 µM suggests complex structure-activity relationships, which may be 
influenced by the combinations of receptor types that are expressed in different organs. Further 
investigation of this issue will be possible if the receptors that mediate the effects of 
SALMFamides are identified (see [28] for a discussion of a potential strategy for identification 
of SALMFamide receptors). If there are multiple receptor types that mediate the effects of 
SALMFamides, then tissue-specific differential expression of receptor types may explain why 
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dose-dependent differences in the relative activity S1, S2 and a synthetic analog of S2 (SS2) are 
observed. 
From a physiological perspective it is of interest to consider why two peptides (S1 and 
S2) with the same effect (muscle relaxation) but with different potencies both exist in starfish. 
Immunocytochemical studies have revealed that S1 and S2 are expressed by different 
populations of neurons in the starfish Asterias rubens and this finding is supported by analysis of 
the genome sequence of the starfish Patiria miniata, which has revealed that S1 and an S2-like 
peptide are derived from precursor proteins encoded by different genes [7]. Moreover, in 
Asterias rubens S2 is detected by radioimmunoassay in the perivisceral coelomic fluid whereas 
S1 is not [17]. This suggests that S2 may act as a hormonal signalling molecule in starfish and 
therefore it would be necessary for its potency to be greater than that of S1, which may only act 
more locally as a neurotransmitter or paracrine signalling molecule. Thus, we speculate that the 
structural features of S2 that confer on it greater potency compared to S1 may be molecular 
adaptations for a hormonal signalling role. 
Finally, it has recently been discovered that in the starfish Patiria miniata, S1 is derived 
from a precursor protein that comprises six other putative L-type or L-type-like SALMFamides 
[7]. On the other hand, the S2-like neuropeptide in this species is derived from a different 
precursor protein that comprises eight F-type or F-type-like SALMFamides [7]. Our 
investigation of a structural basis for differences in the activity of S1 and S2, as reported here, 
therefore provides the foundations for further studies on more complex “cocktails” of 
SALMFamides that occur in vivo.   
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FIGURE LEGENDS 
Fig. 1. Comparison of the potency of S1 and S2 as muscle relaxants. A, Graph comparing the 
relaxing effects of S1 (filled bar) and S2 (empty bar) (0.001 – 1 µM) on starfish cardiac stomach 
preparations, expressed as a mean percentage (± SEM; n = 15) of the effect of 1 µM S2. The 
effect of 1 µM S1 is not significantly different (p = 0.71; t-test) to the effect of 0.1 PM S2 and 
the effect of 0.1 PM S1 is not significantly different (p = 0.89; t-test) to the effect of 0.01 PM S2. 
B, Graph comparing the relaxing effects of S1 and S2 (0.1 – 10 µM) on starfish tube foot 
preparations, expressed as a mean percentage (± SEM; n = 4 for S1; n = 18 for S2) of the effect 
of 10 µM S2.  
 
Fig. 2. CD spectra of S1 and S2 peptides in water. A, CD of S1 as the temperature changes at 
constant pH (5.3). Varying the temperature from 10qC to 50qC had little effect on the CD 
spectra, with just a slight reduction in the amplitude of the CD signal. B, CD of S1 as the pH 
changes from pH 5.3 to pH 8.3 at constant temperature (11qC). Similarly, there is a slight 
reduction in the amplitude of the CD signal as the pH increases. In both A and B there is a strong 
negative band at 200 nm characteristic of a random coil conformation. C. CD of S2  at different 
temperatures and constant pH (5.5). Increasing the temperature from 10qC to 50qC results in a 
slight reduction in the amplitude of the negative bands at 196 nm and 207 nm. D, Increasing the 
pH (at a constant temperature of 11qC) from 5.5 to 8.4 reduces the negative band at 196 nm and 
causes the negative band at 207 nm to shift to longer wavelengths.  
 
Fig. 3. ROESY spectrum of S1. The HD-HN fingerprint region of the S1 neuropeptide ROESY 
(Wm 300 ms) spectrum at 293K, pH 5.6, showing the dDN(i, i+1) assignments of S1. The box 
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around F2 denotes the HD-HN peak that is observed in the TOCSY spectrum but not in the 
ROESY spectrum. 
 
Fig. 4. NMR data for S2 highlights the presence of structure. A, The HD-HN finger print region of 
the S2 TOCSY (Wm 75 ms) spectrum in water at 303K, pH 5.6 showing spin-system assignment. 
B, The HD-HN fingerprint region of the S2 NOESY (Wm 300 ms) spectrum in water at 303K, pH 
5.6. Solid lines show the dDN(i, i+1) sequential assignments of S2. Dashed lines identify residues 
from the cis-Pro3 isoform. 
 
Fig. 5: Concentration dependence of S2 peptide structure and folding stability. Far UV-CD 
spectra of S2, showing concentration dependent secondary structure of S2 at 0.01 mg/ml (7.8 
µM) (red), 0.1 mg/ml (78 µM) (black) and 0.2 mg/ml (156 µM) (blue) (A). Thermal denaturation 
of S2, between 10-90oC, blue spectra are from 10oC and red are at 80oC.  Spectra were obtained 
at two concentrations; 0.1 mg/ml (B), and 0.01 mg/ml of S2 (C). Inserts are thermal denaturation 
curves at 210 nm and 228 nm, respectively.  
 
Fig. 6. NMR analysis of SS2 (short S2). A, the HD-HN fingerprint region of the TOCSY (blue, Wm 
65 ms) and ROESY (red, (Wm 300 ms) spectra of SS2 shown overlaid. The sequential dDN(i, i+1) 
assignments are shown with solid lines.  B, HD chemical shift analysis of S2 (black bars) and SS2 
(white bars). C, HD chemical shift analysis of S1. 
 
Fig. 7. Analysis of the effects of SS2 as a muscle relaxant and comparison of the activity of SS2 
with S1 and S2. A, SS2 causes dose-dependent relaxation of starfish cardiac stomach 
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preparations; error bars represent mean ± SEM (n=5) and data are normalised to the effect of S2 
at 10 PM. B, Comparison of the relaxing effect of SS2 to that of S2 and S1 on cardiac stomach 
(all at 1 PM). Data are normalised to relaxation effect of S2 (at 1 PM); error bars represent mean 
± SEM (n=12). Significance *** = p < 0.001 (students t-test). C, SS2 causes dose-dependent 
relaxation of starfish tube foot preparations; error bars represent mean ± SEM (n=9) and data are 
normalised to the effect of S2 at 10 PM. D, Comparison of the relaxing effect of SS2 to that of 
S2 and S1 on tube feet. Data are normalised to relaxation effect of S2 (1 PM); error bars 
represent mean ± SEM (n=13). Significance *** = p < 0.001, *  =  p<0.05. 
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L10 -4.6 
T11 -5.3 
F12 -6.7 
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 Residue Chemical shift (d) ppm 
NH aH bH others 
Ser1   trans - 4.19 4.00, 3.98 
           cis - 4.19 4.04, 3.99 
Gly2   trans 8.54 4.15 
           cis 8.47 3.68 
Pro3   trans - 4.35 1.94, 2.15 1.79, 1.72 (Hg); 3.56(Hd) 
           cis - 4.40 2.30, 1.96 1.83, 1.65 (Hg); 3.45(Hd) 
Tyr4   trans 8.15 4.55 2.90, 2.98 6.81, 7.08 
           cis 8.50 - 2.73, 3.03* 6.77 ,7.12 
Ser5   trans 7.95 4.36 3.72 
           cis 8.22 4.31 3.78 
Phe6 8.10 4.57 3.10, 3.36 7.34, 7.25, 7.28 
Asn7 8.26 4.66 2.77, 2.67 7.50, 6.83 
Ser8 8.19 4.33 3.90, 3.86 
Gly9 8.33 3.93 
Leu10 7.92 4.35 1.58, 1.54 1.49, 0.89, 0.84 
Thr11 7.96 4.35 4.10 1.08 
Phe12 8.09  4.60 3.15, 2.98 7.33, 7.25, 7.28 
-NH2 7.46, 7.02 
Table S1. Chemical shifts for (A) S1 and (B) S2.  Chemical shifts for the S2trans isoform are also available 
from the BMRB (Accession code 18940) 
 Residue Chemical shift (d) ppm 
NH aH bH others 
Gly1 - - 
Phe2 8.53 4.54 - 7.15 (Hd), 7.22 (He) * 
Asn3 8.37 4.59 2.98, 2.92 7.48 , 6.82 
Ser4 8.21 4.16 2.68, 2.57 
Ala5 8.18 4.16 1.26 
Leu6 7.79 4.13 1.43 0.80, 0.73  
Met7 7.92 4.24 1.78 2.30 (Hg) 
Phe8 7.96 4.51 3.82, 3.73 7.15 (Hd), 7.22 (He)  
A. 
B. 
* Ambiguous. Overlap with Phe8 
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Figure S1. The complete S2 600 MHz NOESY (tm = 300 ms) spectrum collected in water at 303K, pH 
5.6. The NOEs between the Hd, Hg and Hb protons of both the cis and trans isoforms of Pro3 are 
highlighted.  The strong dad(i, i+1)  crosspeak between Gly2 and Pro3 in the trans isoform is also 
highlighted. 
w1 1H ppm 
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